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Background and purpose: to determine if diabetes mellitus is a risk factor for outcome after carotid endarterectomy
(CEA).
Methods: the outcome and complications of all vascular procedures performed in Sweden are registered prospectively in
the Swedish Vascular Registry (Swedvasc) and form the basis of this report. During the 10-year period 1987–96 2622
CEAs were analysed for notified complications.
Results: of the 2622 CEAs, 341 (13%) were performed on diabetics and 2281 (87%) on non-diabetics. Patients with
diabetes presented at a younger age (67.1–8.3 years vs. 68.2–8.3 years; p=0.028), were more likely to have a history
of hypertension (61.9% vs. 50%; p=0.001) and were less often smokers (34.9% vs. 43.2%; p=0.001). Diabetics presented
more often with minor stroke (41.3% vs. 30.8%; p=0.002) and non-diabetics more often with amaurosis fugax (18.9%
vs. 14.4%; p=0.04). Diabetics had a higher 30-day mortality (3.2% vs. 1.4%; p=0.02). The 30-day neurologic and
cardiac morbidity did not differ. The 1-year mortality was 7.9% in diabetics and 4.4% in non-diabetics (p=0.008). Non-
diabetics operated on in 1992–96 compared to those operated on in 1987–91 had a significantly lower combined permanent
stroke and death rate (3.7% vs. 5.7%; p=0.05), a difference not found in diabetics (6.3% for 1987–92 and 6.8% for
1992–96; n.s.).
Conclusions: diabetics had both a higher 30-day and 1-year mortality after CEA compared to non-diabetics, mainly
because of cardiac complications. However, postoperative neurologic morbidity did not differ.
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Introduction selected patients with symptomatic high-grade in-
ternal carotid artery (ICA) stenosis, is confirmed in
Diabetes mellitus is a major risk factor for the de- several randomised clinical trials.7–9 However, the long-
velopment of ischaemic stroke. Patients with diabetes term benefit of CEA is dependent on low perioperative
are at least two times more likely to suffer from a stroke and mortality rates. The major causes of serious
stroke than non-diabetics.1,2 The difference persists perioperative morbidity and mortality are stroke and
even when adjusted for hypertension, cholesterol, cardiovascular disease.10,11
smoking, obesity, and, after excluding individuals with Some investigators have suggested that diabetics
previous history of stroke, myocardial infarction (MI) have a higher incidence of postoperative complications
or congestive heart failure (CHF).3 In addition, stroke after CEA.12,13 On the other hand, others have not
in diabetics is associated with worse functional out- found a significant difference in stroke and death
come and higher mortality compared to non-dia- between the two groups.14,15 We have analysed data on
betics.4–6 a population basis from the Swedish Vascular Registry.
The benefit of carotid endarterectomy (CEA), in The aim of this study was to compare diabetics and
non-diabetics regarding clinical presentation, the 30-
* See acknowledgements for full list of participating centres and day postoperative neurologic and cardiac morbidity,
surgeons. and the 30-day and 1-year mortality in order to define† Please address all correspondence to: D. Bergqvist, Department of
Surgery, Uppsala University Hospital, S-751 85 Uppsala, Sweden. the safety of CEA in the diabetic population.
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Table 1. Preoperative risk factors registered in Swedvasc. missing value it was negative in 94.8% and positive
in 5.2% of the cases. It therefore seems safe to assumePreoperative risk factors
that a missing value in these patients can be considered
1 History of stroke or TIA as a negative value. On the other hand, when all risk
2 Diabetes (controlled diet, oral hypoglycaemic medication or factors are left as missing values, which was the caseinsulin-dependent)
3 Hypercholesterolaemia (>2SD from normal value) in 73 operations, it is more likely that it is due to
4 Hypertension (medicated or untreated diastolic pressure inadequate notification of risk factors. Together with
>110 mmHg) the 13 operations where diabetes was registered as5 History of MI, angina pectoris, pathologic ECG, arrhythmia,
CHF, CABG unknown, these 73 operations were excluded from our
6 Previous vascular surgery, angioplasty, amputation due to analysis. This resulted in a total of 341 (13%) CEAs
vascular disease performed on 313 diabetics and 2281 (87%) procedures7 Chronic lung disease
8 S-creatinine >150 lmol/l on 2102 non-diabetics analysed in our report.
9 Smoker or former smoker during the last five years The clinical presentation leading to CEA was clas-
sified in the following five groups: asymptomatic,TIA: transient ischaemic attack; MI: myocardial infarction; CHF:
congestive heart failure; CABG: coronary artery bypass graft. amaurosis fugax (transient monocular visual loss),
TIA (ischaemic hemispheric symptoms lasting <24 h),
minor stroke (non-disabling stroke) and other causes.
Materials and Methods The 30-day postoperative neurologic morbidity was
classified as: TIA/AF when there was full recovery
The Vascular Registry in Sweden (Swedvasc) started within 24 h, transient stroke when the neurologic de-
as a regional registry, in the southern parts of the ficit lasted more than 24 h but less than 30 days, and
country, with a population base of 1.9 million. It permanent stroke when the neurologic deficit lasted
has gradually expanded, now covering more than 8.5 more than 30 days. In 46 patients, postoperative neuro-
million people (basically the total Swedish popu- logic morbidity was only registered as a postoperative
lation).16,17 The participating centres report all open neurologic event, with no further specification. Re-
vascular and endovascular surgical procedures. Re- cords for these 46 patients were analysed and classified
operations and complications are reported. Results are as TIA/AF, transient or permanent stroke. All neuro-
reported on standardised forms after 30 days and 1 logic events are reported regardless of whether ip-
year. Mortality data can be cross-checked with The silateral or contralateral to the CEA. All deaths within
National Population Registry, making survival ana- 30 days of the operation are reported, regardless of
lysis possible after the 1-year clinical follow-up. All cause. All cardiac events within 30 days are reported.
centres performing carotid artery surgery in Sweden Data management and statistical analysis were per-
participate in the registry and report their results. formed using the SPSS for Windows program package.
Validation against anaesthesia registries and re- Categorical variables were compared with Fisher’s
producibility control of random samples of cases are exact test and continuous variables with Student’s t-
performed regularly confirming a more than 90% re- test. Preoperative variables that were positively as-
port rate and 90% reproducibility of data.18 sociated with postoperative outcome at a p value less
From January 1987 to December 1996 a total of 2708 than 0.1 were selected for multivariate analysis using
carotid endarterectomies, performed on 2501 patients, binary logistic regression analysis. All tests were two-
were registered in Swedvasc; of these procedures, 341 tailed, and a level of significance set at pZ0.05.
were performed on patients registered as diabetics
(controlled diet, oral hypoglycaemic medication or
insulin-dependent: it is not possible to distinguish the Results
three treatment modalities), 2033 registered as non-
diabetics, 13 registered as diabetes unknown and in Demographic data are reported in Table 2. Patients
with diabetes presented at a younger age (67.1–8.3321 cases missing values with no registration for dia-
betes. Due to the large number of missing values, these years) compared with non-diabetics (68.2–8.3 years;
p=0.028). A significantly greater percentage of non-were analysed separately.
Diabetes is one of several risk factors reported to diabetics were smokers (43.2% vs. 34.9%; p=0.001).
Diabetics had a significantly higher rate of hyper-Swedvasc (Table 1). Of the 321 procedures with missing
values for diabetes, 248 had one or more risk factors tension (61.9%) compared to non-diabetics (50%; p=
0.001). There was no difference in the frequency ofother than diabetes registered. Of these 248 patients a
sample of 120 patient records were analysed for risk previous heart disease between diabetic and non-dia-
betic patients (48.7% vs. 44.1%; n.s.). Previous vascularfactors, showing that when a risk factor was left as a
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Table 2. Clinical characteristics. 4). The major 30-day cause of death was cardiovascular
disease (45.5% diabetics, 45.2% non-diabetics) followedDiabetic Non-diabetic
patients patients by cerebrovascular disease (36.4% diabetics, 38.7%
n=341 (13%) n=2281 (87%) p non-diabetics) with no significant difference between
the two groups. By univariate analysis the combinedAge (year; mean–s.d.) 67.1–8.3 68.2–8.3 0.028
Sex 30-day permanent stroke and death rate was sig-
Male 215 (63%) 1537 (67.4%) n.s. nificantly higher among diabetics (6.7%) compared
Female 126 (37%) 744 (32.6%) with non-diabetics (4.1%; p=0.035). By logistic re-Smoking
Smoker 119 (34.9%) 985 (43.2%) 0.001 gression analysis, however, hypertension was the only
Non-smoker 222 (65.1%) 1296 (56.8%) independent risk factor for combined 30-day per-
History of hypertension manent stroke and mortality (p=0.02). The total 30-Hypertension 211 (61.9%) 1140 (50.0%) 0.001
No hypertension 130 (38.1%) 1141 (50.0%) day postoperative cardiac morbidity (MI, angina, CHF,
History of heart disease arrhythmia) was 4.7% in diabetics and 3.7% in non-
Heart disease 166 (48.7%) 1007 (44.1%) n.s. diabetics (n.s.). The 1-year mortality after CEA wasNo heart disease 175 (51.3%) 1274 (55.9%)
Previous vascular surgery significantly higher among diabetics (7.9% vs. 4.4%;
Previous surgery 66 (19.4%) 442 (19.4%) n.s. p=0.008). Previous heart disease and the male gender
No previous surgery 275 (80.6%) 1839 (80.6%) proved also to be independent risk factors for 1-yearHistory of pulmonary disease
Pulmonary disease 21 (6.2%) 130 (5.7%) n.s. mortality by logistic regression analysis (Table 4).
No pulmonary disease 320 (93.8%) 2151 (94.3%) Non-diabetics operated on in 1992–96 compared to
History of renal disease those operated on in 1987–91 had a significantly lowerRenal disease 14 (4.1%) 81 (3.6%) n.s.
No renal disease 327 (95.9%) 2200 (96.4%) combined 30-day permanent stroke and death rate
(3.7% vs. 5.7%; p=0.05). This decrease in the morbidity
and mortality was not found in diabetic patients, who
had a combined permanent stroke and death rate of
6.3% for 1987–92 and 6.8% for 1992–96 (n.s.).
Table 3. Clinical presentation.
Diabetic Non-diabetic
patients patients Discussion
n=341 (13%) n=2281 (87%) p
Continuous audit of morbidity and mortality afterAsymptomatic 30 (8.8%) 216 (9.5%) n.s.
Amaurosis fugax 49 (14.4%) 431 (18.9%) 0.04 CEA is of great importance for identifying risk factors
TIA 109 (32.0%) 837 (36.7%) n.s. and reducing complications. Reviews of data coming
Minor stroke 141 (41.3%) 702 (30.8%) 0.002
from single institutions are of limited value, since theyOther 12 (3.5%) 95 (4.2%) n.s.
represent the experience of the surgeon(s) preparing
the report.19 Population-based audits provide better
insight in the average risk of perioperative com-
plications.20 An important finding in our series was
the significantly increased 30-day and 1-year mortality
in diabetic patients. However, diabetic patients did notsurgery had been performed in 19.4% of both groups.
Diabetics presented significantly more often with show an increase in postoperative neurologic events,
neither transient nor permanent. There are severalminor stroke (41.3%) compared to non-diabetics
(30.8%; p=0.002), and non-diabetics presented more possible explanations for the higher mortality in dia-
betics after CEA. Diabetics more frequently underwentoften with amaurosis fugax (18.9% vs. 14.4%; p=0.04).
Other clinical presentations did not differ (Table 3). surgery for minor stroke, which in turn has a higher
postoperative complication rate than asymptomaticThe 30-day permanent stroke rate was 3.5% in the
diabetics and 2.8% in the non-diabetics (n.s.). Transient stenosis or TIA/AF. The incidence of preoperative
hypertension was also higher.stroke developed in 1.5% of the diabetics and 2.4% of
the non-diabetics (n.s.), and TIA/AF in 1.8% of the Being a multicentre registry study, there are several
limitations that should be taken into considerationdiabetics and 1.9% of the non-diabetics (n.s.). Diabetics
had a significantly higher 30-day mortality (3.2%) com- when interpreting our results. Our study is totally
dependent on surgeons all around the country re-pared with non-diabetics (1.4%; p=0.02). Apart from
diabetes, a history of previous heart disease was an porting their results and complications accurately. The
registry, which is designed for all vascular proceduresindependent risk factor for the 30-day mortality (Table
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Table 4. Multivariate analysis.
30-day combined 30-day 1-year
stroke and mortality mortality mortality
Univariate Multivariate Univariate Multivariate Univariate Multivariate
Gender p=0.69 p=0.71 p=0.18 p=0.17 p=0.012 p=0.02
Smoking p=0.34 p=0.50 p=0.87 p=0.95 p=0.65 p=0.35
Diabetes p=0.035 p=0.07 p=0.014 p=0.02 p=0.009 p=0.008
Hypertension p=0.006 p=0.02 p=0.054 p=0.09 p=0.056 p=0.12
Heart disease p=0.046 p=0.10 p=0.01 p=0.047 p=0.001 p=0.001
Previous vascular procedure p=0.28 p=0.48 p=0.1 p=0.24 p=0.065 p=0.28
The combined end-point stroke and mortality at 30 days was chosen because it is usually in publications on CEA. Otherwise, mortality
was the main end-point.
and not specifically for CEAs, has some shortcomings. There was also a high frequency of operations for
asymptomatic stenosis reported by Akbari et al.14 (45%The degree of internal carotid stenosis is not reported,
neither is the presence of contralateral pathology nor diabetics, 43% non-diabetics) compared to our series
(8.8% diabetics, 9.5% non-diabetics). Both these char-the use of peroperative shunting. Information about
method of anaesthesia is not registered. Cardiac mor- acteristics point to special selection which was not the
case in our population-based series.bidity is not described in detail. Various cardiac events
(MI, angina, CHF, arrhythmia) are all reported as During recent years there has been an increased
awareness to identify and modify preoperative riskpostoperative cardiac morbidity. One problem is how
reliable the registry is in reporting stroke, but there factors, and an improvement in the postoperative care
of patients undergoing CEA. These may be factorsseem to be few missed ones.21 Finally, with patients
coming from many centres, having been operated leading to the significant decrease of postoperative
morbidity and mortality in non-diabetic patients op-on by different surgeons and with partially different
routines as for pre- and postoperative care, un- erated on in 1992–96 compared to 1987–91. However,
there was no decrease in morbidity and mortalityrecognised confounding variables may have been in-
cluded in our review. between the two periods in diabetic patients. This calls
for an even more meticulous patient selection, riskThere are few previous studies directly focusing
on CEA in diabetic patients and how outcome is factor identification, and medical optimising of the
diabetic population considered for CEA. In conclusion,influenced by the diabetic disease. Akbari et al.14 neither
found a difference in postoperative neurologic mor- diabetics had a significantly higher 30-day and 1-year
mortality, but they did not have a higher postoperativebidity (2.1% diabetics vs. 1.1% non-diabetics; p=0.28)
nor mortality (0.3% total mortality) between diabetics neurologic morbidity. The mortality was mainly car-
diac. There was a significant decrease in postoperativeand non-diabetics. Their patients were followed up
for complications during their postoperative hospital morbidity and mortality in non-diabetics when op-
erations early in the series were compared with morestay (4.1–0.4 days in diabetics and 3.2–0.2 days in
non-diabetics) and not for a full 30-day period, al- recent operations. This trend was not seen in the
diabetics.though previous trials7,8 have shown an increase in
postoperative complications at 30 days. In our series
13% of the operations were performed on diabetics,
which is lower than the 39% reported by Akbari et
al.14 This raises the question whether they had an Acknowledgements
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